According to Sellas Life Sciences's latest financial reports the company's total assets are $6.21 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $20.94 M | -20.29% |
2021-12-31 | $26.27 M | -42.94% |
2020-12-31 | $46.04 M | 177.25% |
2019-12-31 | $16.6 M | -1.81% |
2018-12-31 | $16.91 M | -49.55% |
2017-12-31 | $33.52 M | 422.21% |
2016-12-31 | $6.42 M | -92.18% |
2015-12-31 | $82.14 M | 2.06% |
2014-12-31 | $80.48 M | -8.51% |
2013-12-31 | $87.97 M | 60% |
2012-12-31 | $54.98 M | 77.56% |
2011-12-31 | $30.96 M | 314.23% |
2010-12-31 | $7.47 M | 19.58% |
2009-12-31 | $6.25 M | -39.65% |
2008-12-31 | $10.35 M | -14.72% |
2007-12-31 | $12.14 M | 607250% |
2006-12-31 | $0 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.25 B | 3,952.21% | ๐บ๐ธ USA |